29 May 2018 - Cancer patients would have access to an off-the-shelf immunotherapies to reprogram their immune system to fight tumours at a fraction of the current price, as part of a world-first plan to turn these experimental treatments into ready-made products.

CAR T-cell therapy involves removing a patient’s immune cells, re-engineering them and infusing them back to create a “designer” immune system, usually as a last-ditch attempt to save their life.

While still experimental, it has been able to “melt” cancer away in some blood cancer patients after just months.

Read Daily Telegraph article